197 related articles for article (PubMed ID: 10729920)
1. Colonic mucin-carbohydrate components in colorectal tumors and their possible relationship to MUC2, p53 and DCC immunoreactivities.
Hara A; Saegusa M; Mitomi H; Kurihara M; Ishihara K; Hotta K; Okayasu I
Pathol Res Pract; 2000; 196(3):159-66. PubMed ID: 10729920
[TBL] [Abstract][Full Text] [Related]
2. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene.
Velcich A; Corner G; Palumbo L; Augenlicht L
Oncogene; 1999 Apr; 18(16):2599-606. PubMed ID: 10353603
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in mice genetically deficient in the mucin Muc2.
Velcich A; Yang W; Heyer J; Fragale A; Nicholas C; Viani S; Kucherlapati R; Lipkin M; Yang K; Augenlicht L
Science; 2002 Mar; 295(5560):1726-9. PubMed ID: 11872843
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
[TBL] [Abstract][Full Text] [Related]
5. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
[TBL] [Abstract][Full Text] [Related]
6. Gastric adenomas and superficial adenocarcinomas display distinct patterns of mucin carbohydrate and core protein expression.
Wang YZ; Mitomi H; Kurihara M; Ishihara K; Hotta K; Tanigawa H; Okayasu I
Histopathology; 2000 Sep; 37(3):250-9. PubMed ID: 10971701
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO
Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810
[TBL] [Abstract][Full Text] [Related]
8. The DCC protein and prognosis in colorectal cancer.
Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC
N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
13. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B
Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae.
Bara J; Gautier R; Daher N; Zaghouani H; Decaens C
Cancer Res; 1986 Aug; 46(8):3983-9. PubMed ID: 3524800
[TBL] [Abstract][Full Text] [Related]
15. The distribution of the deleted in colon cancer (DCC) protein in human tissues.
Turley H; Pezzella F; Kocialkowski S; Comley M; Kaklamanis L; Fawcett J; Simmons D; Harris AL; Gatter KC
Cancer Res; 1995 Dec; 55(23):5628-31. PubMed ID: 7585645
[TBL] [Abstract][Full Text] [Related]
16. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.
Reis CA; David L; Correa P; Carneiro F; de Bolós C; Garcia E; Mandel U; Clausen H; Sobrinho-Simões M
Cancer Res; 1999 Mar; 59(5):1003-7. PubMed ID: 10070955
[TBL] [Abstract][Full Text] [Related]
17. Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity?
Tozawa E; Ajioka Y; Watanabe H; Nishikura K; Mukai G; Suda T; Kanoh T; Hatakeyama K
Pathol Res Pract; 2007; 203(8):567-74. PubMed ID: 17679024
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
19. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
Saeki T; Stromberg K; Qi CF; Gullick WJ; Tahara E; Normanno N; Ciardiello F; Kenney N; Johnson GR; Salomon DS
Cancer Res; 1992 Jun; 52(12):3467-73. PubMed ID: 1596904
[TBL] [Abstract][Full Text] [Related]
20. Detection of cancer clones in human colorectal adenoma as revealed by increased DNA instability and other bio-markers.
Jin Y; Sun A; Noriki S; Imamura Y; Fukuda M
Eur J Histochem; 2007; 51(1):1-10. PubMed ID: 17548263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
